Brief: Citius Pharmaceuticals And Citius Oncology Highlight Lymphir Commercial Launch Planned For First Half Of 2025
07/01/2025 13:18
Jan 7 (Reuters) - Citius Pharmaceuticals Inc CTXR.O :
* CITIUS PHARMACEUTICALS AND CITIUS ONCOLOGY HIGHLIGHT
LYMPHIR
COMMERCIAL LAUNCH PLANNED FOR FIRST HALF OF 2025
Source text: ID:nPn5T2r9Sa
Further company coverage: CTXR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Citius Pharmaceuticals
See all newsCitius Pharmaceuticals Q2 revenue rises on LYMPHIR launch
Citius Pharmaceuticals reports first revenue of $3.9 mln
Brief: Citius Oncology Expands International Distribution Of Lymphir™ To European Union Through Exclusive Agreement With Uniphar
Brief: Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results And Provides Business Update
Brief: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering And Private Placement Priced At-The-Market Under Nasdaq Rules